KIES PETER (CIK 1259780) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy INO (8,700 shares), Sell INO (4,688 shares), Buy INO (4,771 shares), Sell INO (2,571 shares), Buy INO (5,010 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 8,700 | $0 |
| 2026-05-21 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 4,688 | $5,766 |
| 2026-05-18 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 4,771 | $0 |
| 2026-05-18 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 2,571 | $3,342 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 5,010 | $0 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 2,965 | $5,307 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 10,634 | $0 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 6,294 | $11,266 |
| 2025-05-16 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 4,771 | $0 |
| 2025-05-16 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 2,566 | $5,004 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 3,997 | $0 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 2,362 | $4,677 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Buy | 5,010 | $0 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | CFO | Sell | 2,960 | $5,861 |
Source: SEC Form 4 filings · as of 2026-05-21